J. Keith Joung, M.D., Ph.D.

J. Keith Joung, M.D., Ph.D.
Co-Founder

J. Keith Joung is a foremost expert on designer gene-editing tools and assessing and improving their safety. He is the Desmond and Ann Heathwood Research Scholar and pathologist at Massachusetts General Hospital, and professor of pathology at Harvard Medical School. Dr. Joung has received numerous awards, including an NIH Director’s Pioneer Award, an NIH Director’s Transformative Research Project R01 Award, an NIH R35 MIRA (Maximizing Investigators Research Award), election into the American Association of University Pathologists, and designation as a “Highly Cited Researcher” for the past three years (2016, 2017, and 2018) by Thomson Reuters/Clarivate Analytics. He serves on the board of directors for the American Society of Gene and Cell Therapy, and the editorial boards of Human Gene Therapy, Genome Biology and Trends in Biotechnology. He has co-founded and continues to advise multiple biotechnology companies, including Editas Medicine, Beam Therapeutics, and Pairwise Plants. Dr. Joung holds a Ph.D. in genetics from Harvard University, an M.D. from Harvard Medical School, and an A.B. in biochemical sciences from Harvard College.